159 filings
DEFA14A
XGN
Exagen Inc
26 Apr 24
Additional proxy soliciting materials
5:07pm
ARS
2023 FY
XGN
Exagen Inc
26 Apr 24
Annual report to shareholders
9:23am
8-K
XGN
Exagen Inc
26 Apr 24
Exagen Inc. Announces Changes to the Board of Directors
8:32am
DEF 14A
XGN
Exagen Inc
Definitive proxy
26 Apr 24
8:31am
10-K
2023 FY
XGN
Exagen Inc
Annual report
18 Mar 24
9:26am
8-K
urqup6xnxzf3
18 Mar 24
Exagen Inc. Reports Strong Fourth Quarter and Full-Year 2023 Results
8:00am
8-K
ai731
8 Jan 24
Exagen Inc. Announces Select Preliminary Full-Year 2023 Results and Reaffirms Guidance
8:00am
8-K
2wju5
11 Dec 23
Departure of Directors or Certain Officers
4:05pm
EFFECT
wqdg 3o883e
30 Nov 23
Notice of effectiveness
12:15am
424B5
9q4jr7ze0 kq
29 Nov 23
Prospectus supplement for primary offering
5:11pm
CORRESP
0y5m3zcrrsc7
28 Nov 23
Correspondence with SEC
12:00am
UPLOAD
dkrgqlfk442b5j3
22 Nov 23
Letter from SEC
12:00am
424B5
bddfa
20 Nov 23
Prospectus supplement for primary offering
8:00am
8-K
pq4wiv8g6mvfmr5r63
17 Nov 23
Entry into a Material Definitive Agreement
4:30pm
8-K
wygn6
13 Nov 23
Exagen Inc. Reports Strong Third Quarter 2023 Results
4:05pm
8-K
nf8gdzpff5z6dn5wl
26 Oct 23
Entry into a Material Definitive Agreement
4:05pm